480 Preliminary evaluation of a novel coronavirus vaccine (CORVax) using electroporation of plasmid DNA encoding a stabilized prefusion SARS-CoV-2 spike protein alone or with transfection of plasmid IL-12
Shawn M. Jensen(Providence Portland Medical Center), Bernard A. Fox(Oregon Health & Science University), Keith W. Wegmann(Providence Portland Medical Center), Christopher Paustian(UbiVac (United States)), Kim Jaffe, Tarsem Moudgil(Providence Portland Medical Center), Walter J. Urba(Providence Portland Medical Center), Mia Han, Daniel O’Connor(IP Australia), Madelein Laws(UbiVac (United States)), Carlo Bifulco(Providence Health & Services), Bianca Nguyen, Rom S. Leidner(Providence Portland Medical Center), David A. Canton(Western University), Christopher G. Twitty, Glenna McDonnell(UbiVac (United States)), Traci Hilton(UbiVac (United States)), Brian Piening(Providence College), Kellie Malloy Foerter, Hong‐Ming Hu(Viva Biotech (China)), John David Rodriguez, Michael Afentoulis(Providence Portland Medical Center)
Cited by 5
Related Papers
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Longitudinal multi-omics of host–microbe dynamics in prediabetes
|Nature|2019|620